[2H9]-Ruxolitinib, racemic mixture
| Catalog Number |
ACMA00065284 |
| Description |
Ruxolitinib is intended for Pharmaceuticals applications. It is a type of targeted cancer drug : a janus-activated kinase inhibitor (JAK). Ruxolitinib is used as a treatment for some myeloproliferative neoplasms such as myelofibrosis or polycythaemia vera. All information about [2H9]-Ruxolitinib is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. |
| Molecular Weight |
315.42 |
| Molecular Formula |
C17H18N6 |
| Purity |
≥95% |
| Isotopic Enrichment |
98% 2H |
| Stability |
≥1 year |
| Unlabeled CAS |
941688-05-7 |
Please kindly note that our products and services are for research use only.
